BBNX – beta bionics, inc. (US:NASDAQ)
Stock Stats
News
Beta Bionics (BBNX) was downgraded by Weiss Ratings from "sell (d-)" to "sell (e+)".
Beta Bionics (BBNX) had its price target lowered by Leerink Partners from $25.00 to $24.00. They now have an "outperform" rating on the stock.
Beta Bionics (BBNX) had its price target lowered by Stifel Nicolaus from $22.00 to $20.00. They now have a "buy" rating on the stock.
Beta Bionics projects $131M-$136M 2026 revenue and raises gross margin outlook to 57.5%-59.5% [Seeking Alpha]
Beta Bionics, Inc. (BBNX) Reports Q1 Loss, Misses Revenue Estimates [Yahoo! Finance]
Form 10-Q Beta Bionics, Inc. For: Mar 31
Form 8-K Beta Bionics, Inc. For: Apr 21
Form ARS Beta Bionics, Inc. For: Dec 31
Form DEFA14A Beta Bionics, Inc.
Form DEF 14A Beta Bionics, Inc. For: May 21
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.